Genscript Biotech Corporation (FRA:G51)
Germany · Delayed Price · Currency is EUR 1.516
+0.044 (3.02%)
Last updated: Jan 8, 2026, 8:06 AM CET
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of €3.46 billion as of January 9, 2026. Its market cap has increased by 36.62% in one year.
Market Cap
3.46B
Enterprise Value
3.12B
Revenue
705.13M
Ranking
n/a
PE Ratio
1.30
Stock Price
€1.52
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 249.76M to 3.46B, an increase of 1,283.46%. That is a compound annual growth rate of 29.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 3.46B | 16.29% |
| Dec 31, 2025 | 2.97B | 13.27% |
| Dec 31, 2024 | 2.62B | -46.27% |
| Dec 29, 2023 | 4.88B | -22.58% |
| Dec 30, 2022 | 6.31B | -22.85% |
| Dec 31, 2021 | 8.17B | 251.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |